The stock looks very attractive, and they have a potential cancer drug and a potential Alzheimer's drug,
The stock looks very attractive, and they have a potential cancer drug and a potential Alzheimer's drug,
My opinion is it's only natural for the Nasdaq composite to undergo some profit taking after a 30-plus percent advance in two months. Also, many groups that have been very strong -- like the semiconductor group, the drug group -- these are up against relative strength resistance. So it stands to reason that they're going to be profit taking,
© 2020 Inspirational Stories
© 2020 Inspirational Stories